Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
124850982 | 12485098 | 2 | F | 20160726 | 20160621 | 20160817 | PER | US-PFIZER INC-2016307422 | PFIZER | 73.00 | YR | F | Y | 0.00000 | 20160817 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
124850982 | 12485098 | 1 | PS | AROMASIN | EXEMESTANE | 1 | Oral | 25 MG, 1X/DAY | 20753 | 25 | MG | COATED TABLET | QD | ||||||
124850982 | 12485098 | 2 | C | VITAMIN B3 | NIACIN | 1 | UNK | 0 | CAPSULE, SOFT | ||||||||||
124850982 | 12485098 | 3 | C | CALCIUM | CALCIUM | 1 | UNK | 0 | |||||||||||
124850982 | 12485098 | 4 | C | VITAMIN D3 | CHOLECALCIFEROL | 1 | UNK | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
124850982 | 12485098 | 1 | Breast cancer stage IV |
124850982 | 12485098 | 2 | Breast cancer stage IV |
124850982 | 12485098 | 3 | Metastases to bone |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
124850982 | 12485098 | Breast cancer stage IV | |
124850982 | 12485098 | Disease progression |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
124850982 | 12485098 | 1 | 20120524 | 20160515 | 0 |